J. Steven Cole (President)
Brings a unique profile to international business development. Mr. Cole lived in Japan for eight years and is fluent in Japanese. He brings with him many high level successful international pharmaceutical contacts that he has developed over 35 years in the health care industry. Mr. Cole has previously served as Senior VP responsible for all worldwide International Operations at A.H. Robins and VP of Asia/Pacific and Canada for G.D. Searle and Company. Additionally, he was a member of the Searle Pharmaceutical Executive Committee and served on boards of various joint ventures. Mr. Cole was also Chairman of the PMA Far Eastern Committee and the PMA Japan Special Committee on trade barriers.
Mr. Cole is a graduate of the University of Wisconsin, Madison and of the American Graduate School for International Business (Thunderbird).
Stevan F. Schweighardt (Executive Vice President)
Has over 25 years experience in the pharmaceutical, medical device, and diagnostic industries. He is a member of the Licensing Executive Society. Mr. Schweighardt's focus includes Europe , the U.S, and Japan.
Prior positions include serving as President of a development stage company and as a member of the Board of Directors of several start-up companies; Director of Marketing and Acquisitions for Central Diagnostic Laboratory where he formed a new diagnostic division and helped grow the company from $40 million to over $120 million in sales. At G.D. Searle and Company he held sales, marketing, and business development positions.
Mr. Schweighardt is a graduate of the University of Wisconsin, Madison, and holds a Masters Degree in Business Administration from the Lake Forest School of Management. He is a member of the Licensing Executives Society.
Tom Keller (Senior Vice President)
Has 35 years experience in the pharmaceutical and health care field. In various company and consulting positions, he has achieved outstanding results in product management, strategic planning, new product planning, R&D liaison, and marketing research.
Mr. Keller was a Senior Marketing Director at G.D. Searle & Co. and directed marketing programs and staff for cardiovascular, female health care, and central nervous system products. In a prior position as Calan ® -SR Product Director, his industry peers voted him Medical Advertising News "Pharmaceutical Marketer of the Year." Other positions included Director, Promotion Management for all products and Director, Marketing Research and New Product Planning.
Mr. Keller received a BS in Pharmacy degree from the University of Maryland. He earned an MBA in marketing and international business from Northwestern University's Kellogg School of Management.
Tatsuo Arita (Director, Japan)
Heads the Japanese office of Cole & Associates. Mr. Arita, a registered pharmacist, is bilingual in Japanese and English. Mr. Arita has over 40 years experience in all aspects of the Japanese pharmaceutical and medical industries. He is founder and editor of the Japan PharmaCyclopedic, one of the most comprehensive data sources on the Japanese pharmaceutical market
Mr. Arita's positions have included Executive VP of Searle Japan , as well as Director of Manufacturing, Regulatory, New Product Development, Commercial Development and operation of an OTC company. Further, Mr. Arita is highly knowledgeable in the Japanese retail pharmacy system, his family having owned a chain of over 600 pharmacies.
Mr. Arita is a graduate of Osaka Pharmaceutical College, Osaka University.
Klaus Jülicher (Director, Europe)
Heads the European office of Cole & Associates. Mr. Jülicher brings remarkable international experience to us. He lived for 6 years in Taiwan as Country Manager pharmaceuticals for the former Hoechst AG, then moved on to work in Japan for nearly 14 years as Regional Marketing Director Far East for GD Searle, President of Cutter Japan and President of Bayer Yakuhin.
After 20 years of service abroad, he moved back to Germany to head Marketing and Sales for Bayer's pharmaceutical business in Europe. He then joined Schwarz Pharma AG as a Board Member responsible for world-wide marketing and sales and was for 2 years simultaneously running the Schwarz US operations out of Milwaukee.
The last 4 years, Mr. Jülicher lived in London , where he headed Otsuka's European operations with the object of developing a European business for Otsuka. He also served on the Board of the Otsuka parent company as an Executive Director.
Mr. Jülicher is a graduate of Business Management of the University of Erlangen-Nuremberg in Germany.
Kevin M. Cain (Director)
With over 18 years of experience in pharmaceutical, biotechnology, medical device, and diagnostic industries, his experience includes work at both large companies and start-up ventures, within the US and abroad. Previous experience covers responsibilities in marketing research, business development, marketing, sales, sales training, and strategic/business planning. His background in a broad range of functional capacities provides him with a unique perspective in addressing clients' special needs.
Mr. Cain's corporate experience includes serving as International Marketing Director, Metabolic Therapeutics for Serono, Inc, one of the largest biotechnology companies worldwide. His responsibilities were to expand the Metabolics portfolio worldwide, with primary emphasis in Latin America and Japan. At Migliara/Kaplan Associates, he provided analytical and consulting services for smaller companies as well as larger biopharmaceutical clients such as Pfizer, Genentech, Genzyme, and Abbott Laboratories. Other experience include providing consultant services and serving on the Board of Directors for a medical device start-up company. Prior to this, he was the Business Development Manager at Boehringer Mannheim, where he was extensively involved in their US commercialization efforts.
Mr. Cain holds a BS degree in Agricultural and Business Economics from Cook College, Rutgers University. |
